Coronavirus (COVID-19) and intellectual property rights

The following IP practice note provides comprehensive and up to date legal information covering:

  • Coronavirus (COVID-19) and intellectual property rights
  • IP deadlines and procedures
  • IP infringement and enforcement
  • Crown use and compulsory licensing
  • Royalty-free licences
  • Collaborations
  • IP indemnities
  • Court processes and proceedings
  • Contractual obligations and rights
  • Artificial intelligence (AI)
  • More...

Coronavirus (COVID-19) and intellectual property rights

This Practice Note discusses some of the key considerations and implications for IP practitioners during the coronavirus (COVID-19) pandemic. It also includes a table containing an archive of news items on coronavirus and coronavirus developments that relate to IP.

For a discussion about the impact of the pandemic on IP strategy and practice, see News Analysis: Coronavirus (COVID-19)—the impact on IP strategy and practice.

IP deadlines and procedures

In light of the coronavirus pandemic and associated guidance on social distancing, offices were closed and some postal services suspended. In response to such measures, the UK Intellectual Property Office (IPO), World Intellectual Property Office (WIPO), European Patent Office (EPO) and EU Intellectual Property Office (EUIPO) announced changes to various IP deadlines and procedures. These announcements are tracked in the IP coronavirus tracker below and the IPO, WIPO, EPO and EUIPO have created dedicated and maintained coronavirus pages. Due to the fast-paced nature of the coronavirus crisis, it is essential to check these sites before undertaking any IP procedures during this time. For more information on:

  1. IPO tribunals and hearings, see: Alterations to our services—tribunals and hearings

  2. IPO patent procedures, see: Alterations to services—patents

  3. IPO trade marks and designs procedures, see: Alterations to services—trade marks and designs

  4. general information relating to IP service at WIPO, see: Covid-19 Update: WIPO’s IP Services

  5. WIPO COVID-19

Popular documents